Role of anterior vitreous, managing retinal folds in retinal detachment cases

Video
Conference|EURETINA

Dr Grazia Pertile discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

Additional EURETINA coverage

Related Videos
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Dr Ali Erginay discusses his EURETINA presentation
Related Content
Carbomer-containing gels from Aacarb, Aacomer and Puroptics could be at risk of contamination. Images courtesy of MHRA.

MHRA issues safety recall for dry eye gel treatments

November 28th 2023
Article

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

A researcher in personal protective equipment looks at a white rabbit in a glass tank. Image credit: ©Elnur – stock.adobe.com

Novel 3D-printed device may offer a new method to test pharmaceuticals

November 28th 2023
Article

Moving toward eliminating drug and chemical safety testing in animals

A person holds a phone in their hand. Above the phone, icons such as a cross, a pill, a wheelchair and a syringe indicate they are looking at health information. Image credit: ©Monster Ztudio – stock.adobe.com

Harnessing digital media for enhanced patient engagement and outcomes

November 27th 2023
Article

Patients who received digital education demonstrated a better understanding of their disease and its management

Marco A. Zarbin, MD, PhD, Professor of Ophthalmology, Rutgers New Jersey Medical School

AAO 2023: Marco A. Zarbin, MD, PhD, provides analysis of the YOSEMITE and RHINE clinical trials

November 24th 2023
Article

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials

Documents indicate a corporation filing for bankruptcy. Image credit: ©Minerva Studio – stock.adobe.com

Oxurion NV will file for bankruptcy following KALAHARI data release

November 20th 2023
Article

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Intraoperative fluorescein angiography with fluorescein mode, patient with pars planitis with peripheral leakage.

The future is now: Innovations in vitreoretinal surgery 3D viewing systems and robotics

November 16th 2023
Article

Developing technology may offer marked improvements in surgical precision

© 2023 MJH Life Sciences

All rights reserved.